Researchers and the participants who enroll in their clinical trials do not always speak the same language, making it difficult to share trial results with study participants.
As a result, most clinical trial participants are not told the results of the study in which they were involved, though most would like to know, and most researchers would like to tell them, report Medical University of South Carolina (MUSC) researchers in an article published in the Journal of Clinical and Translational Science.
Helping researchers to learn how to translate their findings for a lay public could make participants feel like respected partners in research and potentially increase the number of patients willing to enroll in trials.
Study participants deserve the right to hear those results and know their efforts made a difference, said the two National Institutes of Health-funded MUSC translational researchers who led the study: senior author Teresa J. Kelechi, R.N., Ph.D., associate dean for research in the MUSC College of Nursing, and lead author Cathy L. Melvin, Ph.D., a professor in the Department of Public Health in the MUSC College of Medicine. The study was funded by a special commission pilot project grant from the South Carolina Clinical & Translational Research (SCTR) Institute, the Clinical and Translational Science Awards hub headquartered at MUSC.
Translational research is about "translating" research breakthroughs into clinical practice, but it is also about translating research results into meaningful messages for members of the community, particularly those who made the research possible.
"So part of translation is not only translating from bench to bedside but also translating your findings back to the participants who made it work," said Kelechi. "At the end of the day, it's because of them that we're doing science."
Kelechi and Melvin interviewed and ran focus groups for past study participants to find out whether and how they would like to receive study results. The study also canvassed researchers to determine whether they were willing to share results and identify any barriers to doing so.
Of the 48 past study participants surveyed, almost 70% never received the results from the study in which they participated, though 75% would have liked to. The vast majority of researchers surveyed - 95% - thought it was important, and even an ethical duty, to report findings to study participants.
If informed of findings, many study participants also expressed a willingness to share them with friends, health care providers and others with the same condition. As such, participants could become champions for research in the community, helping to disseminate findings while encouraging others to participate through their example.
Study participants expressed different preferences for how to receive study findings, based on their ages. Two groups of study participants were surveyed: teens/young adults and adults older than 50. The top preference for both groups was email, but older adults greatly preferred mailed letters, postcards, newsletters or calls to texts or social media, while teens/young adults expressed a strong preference against mailed correspondence or newsletters.
The researchers surveyed said they had received little training in communicating to a lay public through age-appropriate channels. Several of the surveyed researchers expressed a desire for more training through workshops as well as templates for a variety of communication documents.
"For me, this was an eye-opening experience," said Kelechi. "I've been doing research for 20 years but was unaware how much the research community feels unequipped to report their findings to study participants. They want to give back, but that is not a skill set that they have, but it is one they want to develop."
To meet that need, Kelechi and Melvin have already developed a number of communication templates and are currently working to refine them further. They also would like to develop lunch and learns and an online module on the topic. At MUSC, researchers can also request recruitment consults and marketing assistance from SCTR via the electronic tool SPARCRequest.
Researchers were also unsure if they should communicate preliminary, partial or equivocal findings to participants. Melvin thinks they should. "Whatever the results are, researchers have a responsibility to share that information back to the participants," she said.
Funding can be another barrier for researchers. Most monies dedicated to communication in a grant are used to recruit patients, leaving little at the end of the study to cover the costs of disseminating the findings. Kelechi suggests that researchers buy postage and other supplies ahead of time to ensure that they have the necessary resources at the end of the study.
Kelechi and Melvin are confident that the gap in communication between researchers and study participants can be bridged.
"We have two groups of people who want the same thing, which is to share information with each other," said Melvin. "So, given the good will on both sides, I'm very optimistic and feel that there is a real opportunity for us to make a difference in this area."
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Founded in 1824 in Charleston, the Medical University of South Carolina (MUSC) is the oldest medical school in the South, as well as the state's only integrated, academic health sciences center with a unique charge to serve the state through education, research and patient care. Each year, MUSC educates and trains more than 3,000 students and 700 residents in six colleges: Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing and Pharmacy. The state's leader in obtaining biomedical research funds, in fiscal year 2018, MUSC set a new high, bringing in more than $276.5 million. For information on academic programs, visit http://musc.
As the clinical health system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest quality patient care available, while training generations of competent, compassionate health care providers to serve the people of South Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach sites, the MUSC College of Medicine, the physicians' practice plan, and nearly 275 telehealth locations, MUSC Health owns and operates eight hospitals situated in Charleston, Chester, Florence, Lancaster and Marion counties. In 2019, for the fifth consecutive year, U.S. News & World Report named MUSC Health the number one hospital in South Carolina. To learn more about clinical patient services, visit http://muschealth.
MUSC and its affiliates have collective annual budgets of $3 billion. The more than 17,000 MUSC team members include world-class faculty, physicians, specialty providers and scientists who deliver groundbreaking education, research, technology and patient care.
About the South Carolina Clinical & Translational Research Institute
The South Carolina Clinical and Translational Research (SCTR) Institute is the catalyst for changing the culture of biomedical research, facilitating sharing of resources and expertise, and streamlining research-related processes to bring about large-scale, change in the clinical and translational research efforts in South Carolina. Our vision is to improve health outcomes and quality of life for the population through discoveries translated into evidence-based practice.
About the Clinical & Translational Science Awards Program
The Clinical & Translational Science Awards (CTSA) Program supports an innovative national network of medical research institutions -- called "hubs" -- that work together to improve the translational research process to get more treatments to more patients more quickly.